Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Zosano Pharma (ZSAN)

Zosano Pharma (ZSAN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Zosano Pharma 34790 ARDENTECH COURT FREMONT CA 94555 USA

www.zosanopharma.com P: 510-745-1200

Description:

Zosano Pharma Corporation is a biopharmaceutical company. It is engaged in developing a transdermal micro needle patch system to deliver formulations of existing drugs through the skin for the treatment of a variety of indications. The Company's lead product candidates include Weekly ZP-PTH for severe osteoporosis; ZP-Glucagon for severe hypoglycemia and ZP-Triptan, for migraine. Zosano Pharma Corporation is headquartered in Fremont, California.

Key Statistics

Overview:

Market Capitalization, $K 2,734
Shares Outstanding, K 4,902
Annual Sales, $ 790 K
Annual Net Income, $ -29,930 K
Last Quarter Sales, $ 130 K
Last Quarter Net Income, $ -33,410 K
60-Month Beta 3.30
% of Insider Shareholders 2.40%
Float, K 4,785
% Float 97.60%
Short Volume Ratio 0.45

Growth:

1-Year Return -98.29%
3-Year Return -99.42%
5-Year Return -99.94%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 99.38%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -7.86 on 05/13/22
Latest Earnings Date 05/11/22
Earnings Per Share ttm -14.86
EPS Growth vs. Prev Qtr -274.66%
EPS Growth vs. Prev Year -181.00%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-35 on 04/12/22

ZSAN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -177.06%
Return-on-Assets % -119.14%
Profit Margin % -3,788.61%
Debt/Equity 0.00
Price/Sales 3.25
Price/Cash Flow N/A
Price/Book 0.19
Book Value/Share 2.87
Interest Coverage -156.53
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar